Schedule 13G ownership disclosure
TYME TECHNOLOGIES INC COM
Security class unavailable · CUSIP: 90238J103
Event date: 2020-01-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,000,000
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-004909
- Form type
- SC 13G
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Jan 17, 2020
- Reporting period
- Jan 07, 2020
- Description
- Schedule 13G beneficial ownership